阿司匹林等环氧化酶抑制剂对食管癌发病风险影响的系统评价与Meta分析(9)
[56] Marrogi AJ，Travis WD，Welsh JA，et al. Nitric oxide synthase，cyclooxygenase 2，and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma[J].Clin Cancer Res，2000，6：4739-4744.
[57] Gately S. The Contributions of Cyclooxygenase-2 to Tumor Angiogenesis[J]. Cancer and Metastasis Reviews，2000， 19(1-2)：19-27.
[58] Maley CC. The Combination of Genetic Instability and Clonal Expansion Predicts Progression to Esophageal Adenocarcinoma[J]. Cancer Research，2004，64(20)：7629-7633.
[59] Galipeau Patricia C，Li Xiaohong，Blount Patricia L，et al. NSAIDs modulate CDKN2A，TP53， and DNA content risk for progression to esophageal adenocarcinoma[J].PLoS Med，2007，4：e67.
[60] Beales Ian LP，Ogunwobi Olorunseun O. Microsomal prostaglandin E synthase-1 inhibition blocks proliferation and enhances apoptosis in oesophageal adenocarcinoma cells without affecting endothelial prostacyclin production[J].Int J Cancer，2010，126：2247-2255.
[61] Bombardier C. Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention[J]. New England Journal of Medicine，2005，352(11)：1071-1080.
(收稿日期：2020-02-28), 百拇医药(张斯渊 董信春 韩松辰)
[57] Gately S. The Contributions of Cyclooxygenase-2 to Tumor Angiogenesis[J]. Cancer and Metastasis Reviews，2000， 19(1-2)：19-27.
[58] Maley CC. The Combination of Genetic Instability and Clonal Expansion Predicts Progression to Esophageal Adenocarcinoma[J]. Cancer Research，2004，64(20)：7629-7633.
[59] Galipeau Patricia C，Li Xiaohong，Blount Patricia L，et al. NSAIDs modulate CDKN2A，TP53， and DNA content risk for progression to esophageal adenocarcinoma[J].PLoS Med，2007，4：e67.
[60] Beales Ian LP，Ogunwobi Olorunseun O. Microsomal prostaglandin E synthase-1 inhibition blocks proliferation and enhances apoptosis in oesophageal adenocarcinoma cells without affecting endothelial prostacyclin production[J].Int J Cancer，2010，126：2247-2255.
[61] Bombardier C. Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention[J]. New England Journal of Medicine，2005，352(11)：1071-1080.
(收稿日期：2020-02-28), 百拇医药(张斯渊 董信春 韩松辰)